Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Daprica M 5 Tablet ER

Prescription Icon
Prescription Required

Marketer

Aprica HealthCare Pvt Ltd

Salt Composition

Dapagliflozin (5mg) + Metformin (500mg)

Overview Daprica M 5 Tablet ER

Daprica M 5 Extended-Release tablets combine two medications to manage type 2 diabetes. This treatment effectively lowers elevated blood glucose, thus minimizing the risk of severe diabetic complications and cardiovascular disease. Daprica M 5 ER can be taken with meals; consistent daily dosing aids adherence. Dosage is determined by your physician; discontinuation requires their approval to avoid potential blood sugar spikes and associated risks like renal impairment and vision loss. This medication complements a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Common side effects include pharyngitis, rhinitis, nasal stuffiness, cephalgia, nausea, emesis, and diarrhea. Adequate hydration mitigates dehydration. Genital mycotic infections may occur; diligent hygiene is preventative. Prior to starting this medication, discuss any renal or hepatic issues, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals should also seek medical counsel. Limit alcohol consumption as it may exacerbate adverse effects. Regular blood glucose monitoring is essential while using this medicine.

Primary Ingredients of Daprica M 5 Tablet ER

There is no text provided to rephrase. Please provide the text you wish to be rewritten.

Uses of Daprica M 5 Tablet ER

Managing type 2 diabetes

Major Benefits of Daprica M 5 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Daprica M 5 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume this extended-release medication with a meal.

Common Side effects of Daprica M 5 Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Daprica M 5 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Daprica M 5 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

How Daprica M 5 Tablet ER works:

Daprica M 5 Extended-Release tablets contain dapagliflozin and metformin, two antidiabetic agents. Dapagliflozin facilitates urinary glucose excretion, while metformin reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin sensitivity. This dual action leads to improved glycemic management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Daprica M 5 Tablet ER.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Daprica M 5mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Daprica M 5mg tablets are likely unsuitable for use while breastfeeding. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose levels are either elevated or depressed. Refrain from driving should such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Daprica M 5 Tablet ER cautiously. Dosage modification for Daprica M 5 Tablet ER might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Extended-release Daprica M 5 mg tablets require careful administration in individuals with hepatic impairment. Dosage modification of Daprica M 5 mg extended-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Daprica M 5 Tablet ER :

Should you forget to take a Daprica M 5 Tablet ER, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Daprica M 5 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Daprica M 5 Tablet ER
79
MRP 91
13% off